Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community

Lancet Infectious Diseases

Volumn 3, Issue 8, 2003, Pages 501-506

  Aiello, Allison E ^a   Larson, Elaine ^b,c  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DISINFECTANT AGENT; TRICLOSAN;

ANTIBIOTIC RESISTANCE; COMMUNITY CARE; DAY CARE; DISEASE TRANSMISSION; HOUSEHOLD; HUMAN; INFECTION; MICROFLORA; MOLECULAR MECHANICS; PERSONAL HYGIENE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR;

EID: 0042206856     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00723-0     Document Type: Review

References (88)

1. Cohen ML. Epidemiological factors influencing the emergence of antimicrobial resistance. Ciba Found Symp 1997; 207: 223-31.
2. Barza M, Gorbach S, DeVincent SJ. Introduction. Clin Infect Dis 2002; 34 (suppl 3): S71-72.
3. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis. Aug 1998; 178: 577-80.
4. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34: 425-33.
5. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonisation in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 2001; 20: 763-67.
6. Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonisation in children without identifiable risk factors. Pediatr Infect Dis 1999; 18: 410-14.
7. Bhargava HN, Leonard PA. Triclosan: applications and safety. Am J Infect Control 1996; 24: 209-18.
8. Jones RD, Jampani HB, Newman JL, Lee AS. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 2000; 28: 184-96.
9. Levy SB. Antibiotic and antiseptic resistance: impact on public health. Pediatr Infect Dis J 2000; 19: S120-22.
10. Levy SB. Antibacterial household products: cause for concern. Emerg Infect Dis 2001; 7(suppl 3): 512-15.
11. Russell AD. Mechanisms of bacterial insusceptibility to biocides. Am J Infect Control 2001; 29: 259-61.
12. Suller MT, Russell AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 11-18.
13. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature. 1998; 394: 531-32.
14. Heath RJ, Rock CO. A triclosan-resistant bacterial enzyme. Nature 2000; 406: 145-46.
15. Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 2001; 40: 467-497.
16. Slayden RA, Lee RE, Barry CE, 3rd. Isoniazid affects multiple components of the type 11 fatty acid synthase system of Mycobacterium tuberculosis. Mol Microbiol. Nov 2000; 38: 514-25.
17. Parikh SL, Xiao G, Tonge PJ. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 2000; 39: 7645-50.
18. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001; 45: 428-32.
19. Chuanchuen R, Narasaki CT, Schweizer HP. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol 2002; 184: 5036-44.
20. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992; 257: 1050-155.
21. Martinez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002; 15: 647-79.
22. World Health Organization. Containing antimicrobial resistance: review of the literature and report of a WHO Workshop on the Development of a Global Strategy for the Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/99.2. Geneva: WHO, 1999.
23. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 2002; 8: 490-95.
24. Christenson B, Sylvan SP, Noreen B. Drug-resistant Streptococcus pneumoniae in day-care centres in Stockholm County. J Infect 1998; 37: 9-14.
25. Givon-Lavi N, Dagan R, Fraser D, Yagupsky P, Porat N. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin Infect Dis 1999; 29: 1274-80.
26. Boken DJ, Chartrand SA, Moland ES, Goering RV. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural childcare centers. Pediatr Infect Dis J 1996; 15: 667-72.
27. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992; 166: 1346-53.
28. Melander E, Molstad S, Persson K, Hansson HB, Soderstrom M, Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis 1998; 17: 834-38.
29. Boost MV, O'Donoghue MM, Dooley JS. Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong. Epidemiol Infect 2001; 127: 49-55.
30. Samore MH, Magill MK, Alder SC, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 2001; 108: 856-65.
31. Hudspeth MK, Smith TC, Barrozo CP, Hawksworth AW, Ryan MA, Gray GC. National Department of Defense Surveillance for Invasive Streptococcus pneumoniae: antibiotic resistance, serotype distribution, and arbitrarily primed polymerase chain reaction analyses. J Infect Dis 2001; 184: 591-96.
32. Murphy GS Jr, Echeverria P, Jackson LR, Arness MK, LeBron C, Pitarangsi C. Ciprofloxacin- and azithromycin-resistant campylobacter causing traveler's diarrhea in US troops deployed to Thailand in 1994. Clin Infect Dis 1996; 22: 868-69.
33. Fairchok MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates. Clin Infect Dis 1996; 22: 966-72.
34. Chiu SS, Ho PL, Chow FK, Yuen KY, Lau YL. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob Agents Chemother 2001; 45: 2765-70.
35. Rydberg J, Cederberg A. Intrafamilial spreading of Escherichia coli resistant to trimethoprim. Scand J Infect Dis 1986; 18: 457-60.
36. Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996; 38: 829-37.
37. Allen KD, Anson JJ, Parsons LA, Frost NG. Staff carriage of methicillin-resistant Staphylococcus aureus (EMRSA 15) and the home environment: a case report. J Hosp Infect 1997; 35: 307-311.
38. Baran J Jr, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol 2002; 23: 23-26.
39. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286: 1201-05.
40. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999; 14: 606-09.
41. Melander E, Ekdahl K, Jonsson G, Molstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 2000; 19: 1172-77.
42. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996; 313: 387-91.
43. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002; 34: S93-106.
44. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340: 1525-32.
45. Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27: 199-208.
46. Piddock LJV. Quinolone resistance and campylobacter. The medical impact of the use of antimicrobials in food animals; Berlin, Germany; Oct 13-17, 1997. http://www.who.int/emc/diseases/zoo/zoo97_4.html (accessed July 3, 2003).
47. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-98.
48. CDC. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 1999; 282: 1123-25.
49. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-39.
50. Shopsin B, Mathema B, Martinez J, et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000; 182: 359-62.
51. Troillet N, Carmeli Y, Samore MH, et al. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 1998; 19: 181-85.
52. Abudu L, Blair J, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001; 126: 351-56.
53. Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2002; 8: 82-84.
54. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001; 33: 990-96.
55. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7: 178-82.
56. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002; 46: 1147-52.
57. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186: 1344-47.
58. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40: 4289-94.
59. Hiramatsu K, Okuma K, Ma XX, Yamamoto M, Hori S, Kapi M. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Curr Opin Infect Dis 2002; 15: 407-13.
60. Rutala W, Weber D, Barbee S, Gergen M, Sobsey M. Evaluation of antibiotic resistant bacteria in home kitchens. Infect Contr Hosp Epidemiol 2000; 21: 132.
61. Kagan LJ, Aiello AE, Larson E. The role of the home environment in the transmission of infectious diseases. J Comm Health 2002; 27: 247-67.
62. White DG, McDermott PF. Biocides, drug resistance, and microbial evolution. Curr Opin Microbiol 2001; 4: 313-17.
63. Heath RJ, Yu YT, Shapiro MA, Olson E, Rock CO. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem 1998; 273: 30316-20.
64. Hoang TT, Schweizer HP. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol 1999; 181: 5489-97.
65. McMurry LM, McDermott PF, Levy SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999; 43: 711-13.
66. Heath RJ, Su N, Murphy CK, Rock CO. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis. J Biol Chem 2000; 275: 40128-33.
67. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998; 166: 305-09.
68. Levy SB. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002; 49: 25-30.
69. Perencevich EN, Wong MT, Harris AD. National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control 2001; 29: 281-83.
70. Adolfsson-Erici M, Pettersson M, Parkkonen J, et al. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 2000; 46: 1485-89.
71. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002; 36: 1202-11.
72. Akimitsu N, Hamamoto H, Inoue R, et al. Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999; 43: 3042-43.
73. Schweizer HP. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 2001; 202: 1-7.
74. Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control 2003; 31: 124-27.
75. Cookson BD, Farrelly H, Stapleton P, Garvey RP, Price MR. Transferable resistance to triclosan in MRSA. Lancet 1991; 337: 1548-49.
76. Bamber AI, Neal TJ. An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. J Hosp Infect. Feb 1999; 41: 107-09.
77. Sullivan A, Wretlind B, Nord CE. Will triclosan in toothpaste select for resistant oral streptococci? Clin Microbiol Infect 2003; 9: 306-09.
78. Walker C, Borden LC, Zambon JJ, Bonta CY, DeVizio W, Volpe AR. The effects of a 0.3% triclosan-containing dentifrice on the microbial composition of supragingival plaque. J Clin Periodontol 1994; 21: 334-41.
79. Sreenivasan P, Gaffar A. Antiplaque biocides and bacterial resistance: a review. J Clin Periodontol 2002; 29: 965-74.
80. Moken MC, McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob Agents Chemother 1997; 41: 2770-72.
81. Price CT, Singh VK, Jayaswal RK, Wilkinson BJ, Gustafson JE. Pine oil cleaner-resistant Staphylococcus aureus: reduced susceptibility to vancomycin and oxacillin and involvement of SigB. Appl Environ Microbiol 2002; 68: 5417-21.
82. Brooks SE, Walczak MA, Rizwanullah H, Coonan P. Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine. Infect Contr Hosp Epidemiol 2002; 23: 692-95.
83. Block C, Furman M. Association between intensity of chlorhexidine use and microorganisms of reduced susceptibility in a hospital environment. J Hosp Infect 2002; 51: 201-06.
84. Russell AD, Tattawasart U, Maillard JY, Furr JR. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother. 1998; 42: 2151.
85. Loughlin MF, Jones MV, Lambert PA. Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics. J Antimicrob Chemother 2002; 49: 631-39.
86. Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Contr Hosp Epidemiol 1997; 18: 417-21.
87. Tan L, Nielsen NH, Young DC, Trizna Z. Use of antimicrobial agents in consumer products. Arch Dermatol 2002; 138: 1082-86.
88. Aiello AE, Larson EL. What is the evidence for a causal link between hygiene and infections? Lancet Infect Dis 2002; 2: 103-10.